Cargando…

Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly

OBJECTIVES: The purpose of this study is to review the short- and long-term outcomes of high-risk neonates with Ebstein anomaly treated with a newly developed rapid 2-stage Starnes procedure, which is aimed at reducing the size of the enlarged right side of the heart. METHODS: Fifty-two foetuses wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Asou, Toshihide, Kawataki, Motoyoshi, Takeda, Yuko, Asai, Hidetsugu, Tachibana, Tsuyoshi, Toyoshima, Katsuaki, Kim, Ki-Sung, Ueda, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244831/
https://www.ncbi.nlm.nih.gov/pubmed/32463872
http://dx.doi.org/10.1093/ejcts/ezaa139
_version_ 1783716001445052416
author Asou, Toshihide
Kawataki, Motoyoshi
Takeda, Yuko
Asai, Hidetsugu
Tachibana, Tsuyoshi
Toyoshima, Katsuaki
Kim, Ki-Sung
Ueda, Hideaki
author_facet Asou, Toshihide
Kawataki, Motoyoshi
Takeda, Yuko
Asai, Hidetsugu
Tachibana, Tsuyoshi
Toyoshima, Katsuaki
Kim, Ki-Sung
Ueda, Hideaki
author_sort Asou, Toshihide
collection PubMed
description OBJECTIVES: The purpose of this study is to review the short- and long-term outcomes of high-risk neonates with Ebstein anomaly treated with a newly developed rapid 2-stage Starnes procedure, which is aimed at reducing the size of the enlarged right side of the heart. METHODS: Fifty-two foetuses with Ebstein anomaly were analysed in this study and divided into 2 groups. The control group comprised 25 foetuses, referred to us before 2008, and the study group was composed of 27 foetuses, referred to us after 2009. The right atrial area index was defined as high risk when it was >1.5. We applied our management approach to 6 high-risk neonates in the study group. This approach consisted of reducing the size of the right side of the heart through a 2-stage process: (i) right atrial plication without the use of a bypass and (ii) a Starnes procedure. Cox proportional hazards models were used to evaluate the effects of our management approach on the survival rates of the neonates. RESULTS: The mean follow-up period was 7.5 ± 3.3 years. All 6 high-risk neonates in the study group survived. The overall hazard ratio was 0.12 (95% confidence interval of 0.03–0.43) in the study group as compared with the control group (P = 0.0007). A Fontan operation was completed in all but 1 case, with the remaining case awaiting a Fontan operation. CONCLUSIONS: We suggest that a rapid 2-stage Starnes approach can be effective in the treatment of high-risk neonates with Ebstein anomaly.
format Online
Article
Text
id pubmed-8244831
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82448312021-07-01 Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly Asou, Toshihide Kawataki, Motoyoshi Takeda, Yuko Asai, Hidetsugu Tachibana, Tsuyoshi Toyoshima, Katsuaki Kim, Ki-Sung Ueda, Hideaki Eur J Cardiothorac Surg Congenital OBJECTIVES: The purpose of this study is to review the short- and long-term outcomes of high-risk neonates with Ebstein anomaly treated with a newly developed rapid 2-stage Starnes procedure, which is aimed at reducing the size of the enlarged right side of the heart. METHODS: Fifty-two foetuses with Ebstein anomaly were analysed in this study and divided into 2 groups. The control group comprised 25 foetuses, referred to us before 2008, and the study group was composed of 27 foetuses, referred to us after 2009. The right atrial area index was defined as high risk when it was >1.5. We applied our management approach to 6 high-risk neonates in the study group. This approach consisted of reducing the size of the right side of the heart through a 2-stage process: (i) right atrial plication without the use of a bypass and (ii) a Starnes procedure. Cox proportional hazards models were used to evaluate the effects of our management approach on the survival rates of the neonates. RESULTS: The mean follow-up period was 7.5 ± 3.3 years. All 6 high-risk neonates in the study group survived. The overall hazard ratio was 0.12 (95% confidence interval of 0.03–0.43) in the study group as compared with the control group (P = 0.0007). A Fontan operation was completed in all but 1 case, with the remaining case awaiting a Fontan operation. CONCLUSIONS: We suggest that a rapid 2-stage Starnes approach can be effective in the treatment of high-risk neonates with Ebstein anomaly. Oxford University Press 2020-05-27 /pmc/articles/PMC8244831/ /pubmed/32463872 http://dx.doi.org/10.1093/ejcts/ezaa139 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Congenital
Asou, Toshihide
Kawataki, Motoyoshi
Takeda, Yuko
Asai, Hidetsugu
Tachibana, Tsuyoshi
Toyoshima, Katsuaki
Kim, Ki-Sung
Ueda, Hideaki
Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly
title Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly
title_full Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly
title_fullStr Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly
title_full_unstemmed Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly
title_short Rapid two-stage Starnes approach in high-risk neonates with Ebstein anomaly
title_sort rapid two-stage starnes approach in high-risk neonates with ebstein anomaly
topic Congenital
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244831/
https://www.ncbi.nlm.nih.gov/pubmed/32463872
http://dx.doi.org/10.1093/ejcts/ezaa139
work_keys_str_mv AT asoutoshihide rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly
AT kawatakimotoyoshi rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly
AT takedayuko rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly
AT asaihidetsugu rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly
AT tachibanatsuyoshi rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly
AT toyoshimakatsuaki rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly
AT kimkisung rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly
AT uedahideaki rapidtwostagestarnesapproachinhighriskneonateswithebsteinanomaly